Arrowhead Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Arrowhead Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. Its drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. 

CEO
Christopher Richard Anzalone
CEOChristopher Richard Anzalone
Employees
1,059
Employees1,059
Headquarters
Pasadena, California
HeadquartersPasadena, California
Founded
1989
Founded1989
Employees
1,059
Employees1,059

ARWR Key Statistics

Market cap
5.85B
Market cap5.85B
Price-Earnings ratio
-8.12
Price-Earnings ratio-8.12
Dividend yield
—
Dividend yield—
Average volume
3.30M
Average volume3.30M
High today
$44.80
High today$44.80
Low today
$41.17
Low today$41.17
Open price
$43.49
Open price$43.49
Volume
3.91M
Volume3.91M
52 Week high
$95.49
52 Week high$95.49
52 Week low
$37.43
52 Week low$37.43

Stock Snapshot

Arrowhead Pharmaceuticals(ARWR) stock is priced at $41.40, giving the company a market capitalization of 5.85B. It carries a P/E multiple of -8.12.

During the trading session on 2026-11-21, Arrowhead Pharmaceuticals(ARWR) shares reached a daily high of $44.80 and a low of $41.17. At a current price of $41.40, the stock is +0.6% higher than the low and still -7.6% under the high.

Trading activity shows a volume of 3.91M, compared to an average daily volume of 3.3M.

Over the past 52 weeks, Arrowhead Pharmaceuticals(ARWR) stock has traded between a high of $95.49 and a low of $37.43.

Over the past 52 weeks, Arrowhead Pharmaceuticals(ARWR) stock has traded between a high of $95.49 and a low of $37.43.

ARWR News

Investing.com 3d
Arrowhead at jefferies global healthcare conference: launch and pipeline push - Investing.com

...

Arrowhead at jefferies global healthcare conference: launch and pipeline push - Investing.com
Simply Wall St 6d
Analysts Have Lowered Expectations For Arrowhead Pharmaceuticals, Inc. After Its Latest Results

It's shaping up to be a tough period for Arrowhead Pharmaceuticals, Inc. ( ), which a week ago released some disappointing annual results that could have a nota...

Analysts Have Lowered Expectations For Arrowhead Pharmaceuticals, Inc. After Its Latest Results
TipRanks 7d
Arrowhead Pharmaceuticals Earnings Call Signals Commercial Momentum

Arrowhead Pharmaceuticals, Inc. ((ARWR)) has held its Q4 earnings call. Read on for the main highlights of the call. Arrowhead Pharmaceuticals’ earnings call h...

Analyst ratings

94%

of 16 ratings
Buy
93.8%
Hold
6.3%
Sell
0%

People also own

Based on the portfolios of people who own ARWR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.